148 related articles for article (PubMed ID: 24743291)
1. [A case of gastrointestinal stromal tumor of the jejunum successfully treated by preoperative induction chemotherapy with imatinib mesylate administered through jejunostomy and subsequent surgical resection].
Kimura H; Ohtsuka T; Toma H; Ueda J; Mizuuchi Y; Yamamoto H; Takahata S; Oda Y; Ueki T; Tanaka M
Gan To Kagaku Ryoho; 2014 Mar; 41(3):391-4. PubMed ID: 24743291
[TBL] [Abstract][Full Text] [Related]
2. [Peritoneal dissemination from gastrointestinal stromal tumor of small intestine responding completely to imatinib mesylate (STI 571)].
Yamanaka H; Mizushima T; Mikata S; Ito T; Nonaka K; Ide H; Michiura T; Kainuma S; Iwase K
Gan To Kagaku Ryoho; 2005 Dec; 32(13):2125-8. PubMed ID: 16352942
[TBL] [Abstract][Full Text] [Related]
3. Is imatinib justified as an adjuvant chemotherapy for patients with recurrent gastrointestinal stromal tumors.
Lai IR; Hu RH; Chang KJ
Hepatogastroenterology; 2005; 52(63):826-8. PubMed ID: 15966213
[TBL] [Abstract][Full Text] [Related]
4. An invasive extragastrointestinal stromal tumor curably resected following imatinib treatment.
Muto M; Fujiya M; Okada T; Inoue M; Yabuki H; Kohgo Y
J Gastrointestin Liver Dis; 2013 Sep; 22(3):329-32. PubMed ID: 24078991
[TBL] [Abstract][Full Text] [Related]
5. [A case of multiple liver metastases after resection of gastrointestinal stromal tumor of the small intestine that was successfully treated with imatinib mesylate].
Ebisui C; Okada K; Wada Y; Kato R; Makino S; Nishigaki T; Owada Y; Yanagisawa T; Okamura S; Fukuchi N; Murata K; Yokouchi H; Tamai M; Kinuta M
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1708-10. PubMed ID: 24393896
[TBL] [Abstract][Full Text] [Related]
6. Giant GIST of the small intestine in a young man.
Atmatzidis S; Chatzimavroudis G; Ananiadis A; Kapoulas S; Atmatzidis K
J Gastrointest Surg; 2013 Aug; 17(8):1536-7. PubMed ID: 23797887
[TBL] [Abstract][Full Text] [Related]
7. [A case of rectal gastrointestinal stromal tumor in an elderly patient who was successfully treated with imatinib mesylate with no significant adverse events].
Gomi K; Mihara M; Abe M; Ikeda Y; Shimada K; Maruyama K; Kajikawa S; Shirota H
Gan To Kagaku Ryoho; 2014 Jan; 41(1):103-6. PubMed ID: 24423962
[TBL] [Abstract][Full Text] [Related]
8. [Surgical resection of a huge gastric gastrointestinal stromal tumor after preoperative adjuvant chemotherapy].
Minami T; Hiramatsu K; Kato T; Shibata Y; Yoshihara M; Natsume S; Aoba T
Gan To Kagaku Ryoho; 2014 Sep; 41(9):1163-6. PubMed ID: 25248904
[TBL] [Abstract][Full Text] [Related]
9. [Neoadjuvant therapy with imatinib mesilate for gastrointestinal stromal tumor of the stomach before subsequent successful surgical resection].
Yamamoto K; Imamura H; Furukawa H; Kishimoto T; Miyazaki Y; Ohshiro R; Tatsuta M; Ohsato H; Fukunaga M; Nakayama T; Fujimi S; Takemoto H; Kondo M; Kamigaki S; Ohta K; Nakata Y
Gan To Kagaku Ryoho; 2006 Nov; 33(12):1875-7. PubMed ID: 17212133
[TBL] [Abstract][Full Text] [Related]
10. [A case of a giant rectal gastrointestinal stromal tumor radically resectable after treatment with neoadjuvant imatinib mesylate].
Sassa M; Kobayashi Y; Sugeno H; Iwadate M; Suzuki S; Endo Y; Nakamura I; Ohki S; Takenoshita S
Gan To Kagaku Ryoho; 2013 Jul; 40(7):937-41. PubMed ID: 23863741
[TBL] [Abstract][Full Text] [Related]
11. [A case of rectal gastrointestinal stromal tumor (GIST) locally resected after long-term chemotherapy with imatinib mesylate].
Tonooka T; Takiguchi N; Yamamoto H; Nabeya Y; Ikeda A; Kainuma O; Souda H; Cho A; Muto Y; Yanagibashi H; Takano E; Denda T; Nagata M
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1849-51. PubMed ID: 25731351
[TBL] [Abstract][Full Text] [Related]
12. [No recurrent case of the combination of surgical management with chemotherapy].
Hasegawa H; Harada A; Kitagawa D; Nakamura T; Kondo N; Shoji F; Kabashima A; Teramoto S; Funahashi W; Ikeda Y
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2475-7. PubMed ID: 25731562
[TBL] [Abstract][Full Text] [Related]
13. [A case report of two-term surgery for focal progression of a huge liver metastasis and peritoneal dissemination from gastrointestinal stromal tumor during imatinib mesylate treatment].
Toyokawa T; Teraoka H; Kitayama K; Nomura S; Kanehara I; Nishino H
Gan To Kagaku Ryoho; 2014 Mar; 41(3):373-7. PubMed ID: 24743287
[TBL] [Abstract][Full Text] [Related]
14. [A case of recurrent intestinal GIST with long-term survival-beneficial effect of multimodality therapy using high-dose imatinib and surgery].
Akasaka H; Koyama M; Yokoyama H; Morohashi H; Sakamoto Y; Murata A; Hakamada K
Gan To Kagaku Ryoho; 2012 Nov; 39(12):1975-7. PubMed ID: 23267948
[TBL] [Abstract][Full Text] [Related]
15. [A case of gastric gastrointestinal stromal tumor resected after chemotherapy with imatinib].
Kikuchi D; Ishii Y; Saitou M; Yamada M; Takenoshita S
Gan To Kagaku Ryoho; 2011 Jul; 38(7):1201-4. PubMed ID: 21772112
[TBL] [Abstract][Full Text] [Related]
16. [Two cases of recurrent GIST successfully treated with imatinib mesylate at 100mg/day].
Hanada N; Kawata K; Okamura S; Tomiyama N; Hori K
Gan To Kagaku Ryoho; 2013 Jun; 40(6):803-5. PubMed ID: 23863663
[TBL] [Abstract][Full Text] [Related]
17. [Gastrointestinal stromal tumour: our experience].
Versaci A; Macrì A; Ieni A; Terranova M; Leonello G; Saladino E; Speciale G; Famulari C
Chir Ital; 2009; 61(2):161-9. PubMed ID: 19536989
[TBL] [Abstract][Full Text] [Related]
18. [A case of recurrent gastrointestinal stromal tumor with complete response from treatment with reduced dose of imatinib mesylate].
Toyokawa T; Yamashita Y; Yamamoto A; Shimizu S; Inoue T; Ikehara T; Sakashita K; Kanehara I; Teraoka H; Nishiguchi Y
Gan To Kagaku Ryoho; 2012 Nov; 39(11):1723-5. PubMed ID: 23152028
[TBL] [Abstract][Full Text] [Related]
19. [A successfully resected case of liver metastasis of gastrointestinal stromal tumor responding to neoadjuvant chemotherapy with imatinib mesylate and interventional radiology].
Tamura J; Nakayama Y; Kitaguchi K; Ura K; Taira K; Ooe H; Yoshikawa A; Ishigami S; Baba N
Gan To Kagaku Ryoho; 2009 Oct; 36(10):1769-72. PubMed ID: 19838046
[TBL] [Abstract][Full Text] [Related]
20. Two-year adjuvant imatinib mesylate after complete resection of localized, high-risk GIST with KIT exon 11 mutation.
Kang YK; Kang BW; Im SA; Lee JL; Park SR; Kang WK; Chang HM; Kim TW; Oh DY; Jung KH; Ryu MH
Cancer Chemother Pharmacol; 2013 Jan; 71(1):43-51. PubMed ID: 23053257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
